Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically Ill patients

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 528.e7-528.e14

  Malesker, Mark A ^a   Hilleman, Daniel E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

Author keywords

Critical care; Hypertension; Labetalol; Nicardipine

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL; NICARDIPINE;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIASTOLIC BLOOD PRESSURE; DRUG COST; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL COST; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84867334197     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.12.005     Document Type: Article

References (18)

1. Elliott W.J. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis 2006, 48:316-325.
2. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
3. Varon J. Treatment of acute severe hypertension. Drugs 2008, 68:283-297.
4. Marik P.E., Varon J. Hypertensive crises: challenges and management. Chest 2007, 131:1949-1962.
5. Devlin J.W., Dasta J.F., Kleinschmidt K., et al. Patterns of antihypertensive treatment in patients with acute severe hypertension from a nonneurologic cause: Studying the Treatment of Acute Hypertension (STAT) Registry. Pharmacotherapy 2010, 30:1087-1096.
6. Weder A.B., Erickson S. Treatment of hypertension in the inpatient setting: use of IV labetalol and hydralazine. J Clin Hypertens 2010, 12:29-33.
7. Halpern N.A., Alicea M., Krakoff L.R., et al. Postoperative hypertension: a prospective, placebo-controlled, randomized, double-blind trial, with intravenous nicardipine hydrochloride. Angiology 1990, 41:992-1004.
8. Vincent J.L., Berlot G., Preiser J.C., et al. Intravenous nicardipine in the treatment of postoperative arterial hypertension. J Cardiothoracic Vasc Anesth 1997, 11:160-164.
9. Qureshi A.I., Mohammed Y.M., Yahia A.M., et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 2005, 20:34-42.
10. Marx P.G., Reid D.S. Labetalol infusion in acute myocardial infarction with systemic hypertension. Br J Clin Pharmacol 1979, 8(suppl 2):233-238S.
11. Muzzi D.A., Black S., Losasso T.J., et al. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesthesiology 2002, 70:68-71.
12. Kross R.A., Ferri E., Leung D., et al. A comparative study between a calcium channel blocker (nicardipine) and a combined alpha-beta blocker (labetalol) for control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg 2000, 91:904-909.
13. Powers W.J., Zuzulia A.R., Videen T.O., et al. Autoregulation of cerebral blood flow surrounding acute intracerebral hemorrhage. Neurology 2001, 57:18-24.
14. Liu-Deryke X., Janisse J., Coplin W.M., Parker D., Norris G., Rhoney D.H. A comparison of nicardipine and labetalol for acute hypertension management following stroke. Neurocrit Care 2008, 9:167-176.
15. Liu-Deryke X. 2010.
16. Elastrous S., Nouria S., Ouanes B.L., et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med 2002, 28:1281-1286.
17. Peacock W., Baumann B., Borczuk P., et al. CLUE: a comparative effectiveness trial nicardipine versus labetalol in the emergency department. Ann Emerg Med 2010, 56:S34-S35.
18. Treatment Guidelines from the Medical Letter. Cardiovascular drugs in the ICU. 2002; 1: 19-24.